Cargando…
Neuroprotective Efficacy of Methylene Blue in Ischemic Stroke: An MRI Study
Methylene blue (MB) has unique energy-enhancing and antioxidant properties and is FDA-approved drug to treat methemoglobinemia and cyanide poisoning. This study evaluated the efficacy of MB to treat ischemic stroke in rats using longitudinal MRI and behavioral measures. Rats were subjected to 60-min...
Autores principales: | Shen, Qiang, Du, Fang, Huang, Shiliang, Rodriguez, Pavel, Watts, Lora Talley, Duong, Timothy Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836814/ https://www.ncbi.nlm.nih.gov/pubmed/24278191 http://dx.doi.org/10.1371/journal.pone.0079833 |
Ejemplares similares
-
The Effects of Methylene Blue on Autophagy and Apoptosis in MRI-Defined Normal Tissue, Ischemic Penumbra and Ischemic Core
por: Jiang, Zhao, et al.
Publicado: (2015) -
Methylene blue and normobaric hyperoxia combination therapy in experimental ischemic stroke
por: Rodriguez, Pavel, et al.
Publicado: (2016) -
Methylene blue treatment in experimental ischemic stroke: A mini-review
por: Jiang, Zhao, et al.
Publicado: (2016) -
Stroke Neuroprotection: Targeting Mitochondria
por: Talley Watts, Lora, et al.
Publicado: (2013) -
Methylene Blue as a Cerebral Metabolic and Hemodynamic Enhancer
por: Lin, Ai-Ling, et al.
Publicado: (2012)